Biobank: ATBC Study (Finland): Difference between revisions
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::THL Biobank]]. | '''Sponsor, manager or home institution:''' [[dataOwner::THL Biobank]]. | ||
'''Type of information:''' [[hasDataDictionary::Data Dictionary: ATBC Study]]. [https://atbcstudy.cancer.gov/documentation/#diet Click here to learn more]. | '''Type of information:''' [[databaseStructure::longitudinal]]. [[hasDataDictionary::Data Dictionary: ATBC Study]]. [https://atbcstudy.cancer.gov/documentation/#diet Click here to learn more]. | ||
'''Data level:''' [[dataLevel::patient level]]. | '''Data level:''' [[dataLevel::patient level]]. | ||
Revision as of 17:55, 5 June 2024
Go back to Finland page
Type of database: clinical trial database; research study; registry; pharmacovigilance; biobank.
Primary purpose: Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol and/or beta-carotene supplements can reduce the incidence of lung cancer and other cancers.
Sponsor, manager or home institution: THL Biobank.
Type of information: longitudinal. Data Dictionary: ATBC Study. Click here to learn more.
Data level: patient level.
Number of records: About 29,000 sample donors.
Date range: 1985 - 1993
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Data access: not publicly available. Click here to access. Instructions to request data for restricted content click here to access.
Contact information: Click here to access.
